Sauer, Andrea
Boblitz, Lennart
Drick, Nora
Wiestler, Miriam
Scharbau, Michèle
Pries, Philipp
Bollmann, Benjamin-Alexander
Hoeper, Marius M.
Pink, Isabell https://orcid.org/0000-0002-3267-9615
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
Article History
Received: 10 July 2026
Accepted: 10 September 2026
First Online: 19 September 2026
Declarations
Ethics approval and consent to participate: This study was approved by the institutional review board at Hannover Medical School (#9226_BO_K_2020). The study was conducted in accordance with the Declaration of Helsinki, and informed consent was obtained from every patient.
Consent for publication: Not applicable.
Competing interests: MMH has received fees for consultations or lectures from 35Pharma, Acceleron, Actelion, Aerovate, AOP Health, Bayer, Ferrer, Gossamer, Inhibikase, Janssen, Keros, MSD and Novartis outside the submitted work.IP has received fees for lectures from AstraZeneca, GAIA GmbH, BioNTech and StreamedUp outside the submitted work.BAB has received fees for and lectures from AstraZeneca, Bristol-Myers-Sqibb, Boehringer Ingelheim, Coreline, Daiichi-Sankyo, MSD, Novartis, NCO, Novartis, Pfizer and Roche. He also received fees for consultations from AstraZeneca and Siemens outside the submitted work.AS, LB, ND, MW, MS, and PP declare no conflicts of interest.